Scientific Strategy, Oncology

Ataraxis is a clinical AI research lab working at the intersection of multi-modal AI and precision medicine. Our goal is to make disease predictable. To accomplish this, we develop new AI methods that predict patient outcomes and treatment response, and build clinical tools to assist physicians in selecting the most optimal treatments for their patients.

Our AI research lab discovers and develops methods to recognize patterns and predict outcomes across complex, multi-modal clinical data. This spans our causality (Ataraxis™ Tau), foundation model (Falcon and Kestrel for digital pathology), and survival analysis research.

Our first clinical products, such as Ataraxis™ Breast for breast cancer, already help patients get the most appropriate treatment across the best academic institutions and community clinics worldwide.

At Ataraxis, you will have a unique opportunity to shape not only the future of our company, but also the future of healthcare. You will join an exceptional team at the forefront of clinical AI research and deployment. Our advisors include AI pioneers such as our founding advisor, Yann LeCun, and distinguished oncologists from top cancer research institutions, all united by the mission to redefine precision medicine.

Ataraxis has raised over $24 million in funding, including a $20 million Series A led by top venture capital funds such as Thiel Capital/Founders Fund (OpenAI, SpaceX, Palantir), Obvious Ventures (AMI Labs, Inceptive, Radical Numerics, Recursion), and AIX Ventures (Hugging Face, Perplexity).

We are an company with a flat organizational structure, where every team member is empowered to actively contribute. Leadership roles are earned by those who demonstrate initiative and consistently deliver exceptional results. Strong work ethic and the ability to prioritize ruthlessly are essential.

You will lead clinical research expansion of Ataraxis to next cancer types/disease areas beyond breast cancer. Ataraxis has already developed a pan-cancer AI platform that has been internally validated to perform well across various tumor types.

• →

  You will work directly with the CEO and own the expansion of Ataraxis into a new cancer type from early scientific groundwork through the foundation for launch.

• →

  Build and manage a network of relationships with clinical leaders, advisors, and research collaborators.

• →

  Work with our data and partnerships teams to secure and shape the resources our models need.

• →

  Partner with engineering and research to bring the first models in a new indication to life.

• You need relentless drive. This is the thing we care about most. You are the kind of person who, when nobody is going to hand you what you need, goes and gets it anyway. You've done impressive things that weren't required of you. You close loops and you're your own project manager.

• You need to be scientifically fluent. You can discuss clinical studies, translational science, and you can learn details about drugs and trials such that a medical oncologist treats you as a peer. We expect top candidates in this role to have PhD or MS with research/publication track record.

• You need scientific charm. You need to be compelling in conversations with physicians and researchers explaining why our work matters.

• You need to be able to form your own view on complex questions where the information is incomplete, reason from first principles, and trust your intuition, and then update your priors as you learn.

• You need to be very comfortable with modern AI stack and use AI tools to increase your speed (but you know how to avoid AI slop).